Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Research Square|June 19, 2023
MV140 mucosal bacterial vaccine improves uropathogenic E. coli clearance in an experimental model of urinary tract infectionPaula Saz-Leal, Marianne M Ligon, Carmen M Diez-Rivero, et al.
Vaccine|February 27, 2016
Immunisation with proteins expressed during chronic murine melioidosis provides enhanced protection against diseaseOlivia L Champion, Louise J Gourlay, Andrew E Scott, et al.
Vaccines|May 25, 2024
MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract InfectionPaula Saz-Leal, Marianne Morris Ligon, Carmen María Diez-Rivero, et al.
Cell Reports|August 16, 2018
Von Hippel-Lindau Protein Is Required for Optimal Alveolar Macrophage Terminal Differentiation, Self-Renewal, and FunctionHelena M Izquierdo, Paola Brandi, Manuel-José Gómez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 28, 2015
The Blood Transcriptome of Experimental Melioidosis Reflects Disease Severity and Shows Considerable Similarity with the Human DiseaseLaura Conejero, Krzysztof Potempa, Christine M Graham, et al.
American Journal of Respiratory and Critical Care Medicine|March 11, 2021
Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical TrialAntonio Nieto, Angel Mazón, María Nieto, et al.
European Journal of Immunology|August 12, 2017
Human dendritic cells activated with MV130 induce Th1, Th17 and IL-10 responses via RIPK2 and MyD88 signalling pathwaysCristina Cirauqui, Cristina Benito-Villalvilla, Silvia Sánchez-Ramón, et al.
Nature Communications|August 2, 2025
A mucosal vaccine prevents eosinophilic allergic airway inflammation by modulating immune responses to allergens in a murine model of airway diseaseCarmen Sevilla-Ortega, Alba Angelina, Leticia Martín-Cruz, et al.
Frontiers in Immunology|June 21, 2021
Sublingual Bacterial Vaccination Reduces Recurrent Infections in Patients With Autoimmune Diseases Under Immunosuppressant TreatmentSilvia Sánchez-Ramón, Lidia Fernández-Paredes, Paula Saz-Leal, et al.
Cell Reports|January 5, 2022
Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infectionsPaola Brandi, Laura Conejero, Francisco J Cueto, et al.
Pageof 3